Carmel-based NICO Corp. hoping for big boost after clinical trial favors its stroke treatment

Please subscribe to IBJ to decode this article.

qnq.hdmwas we t,ra peeisno tnolitplir ’rweenhh e etct n eioats ueethkrtmfif utllirtrctsy c trliset ofnekuboi iio ,dadyteIansg-oh btsi gta

isrsgarvaeeiath,etcee r-,torvdrasoe ip fttnkbne l h tl nhas rc ihelaCfop ygir otioar oiiai rekdoadvecomnsgclusty rwyge soolc a urnvgl ieobacae nsif rl aavunmanoe lst aahyerclett iebtr h alrefi nN awmtbnnrs eoammo-doien essde.psaire

nlu .ofui0nhoatmbrocrfN edda actomuIc u,piohnr ergoydaocyttoerfeeh3UthhsfO rtitvacaa d t tsnmil rea e bed d i en sowduae0 s.ntskousse tgevaooe piC ihvnsaurbrtpi,,fnaulel te ain nCna Enineloypeoavmt mlt l Ttrisi syr lsvda soeotno

aunl bpoluu%hn k tBeeTlo or,tie 3hrfe n n n i taes ga 3ihiseitwe ten Wrip 0 ohia lyfl eg iuhhete “o asssaIiradnaC—y wlhco oe ”toctJl“s—i.smomJerstarmPse tie swtayOee0. kioa ”hh5o shsnoeh Ererak oehpco rd0mvhprlse dvw ,w%st fyootra rbstsadntgr

e tset uhi awocs,ebu nosvoeit“sdotsNdog te nrIvud iotteco—euhancrli t era yhhC taa rtgalcnds”t s ilute osacrh hmnrletoatd hota u slgIgirihho r serhf leonpuet hp litno re t n mt l.irtrotdnnihurh eOl tnw egopu ate’ nnh ihiorrtddt aai—aotar tot emwtadddrunfanerblfe ne edhisese ra hrst oe.hmasc sa rl N btatwaefCeto uetplivoanre oteoont civ iti

stwnetteitCd a astnvni altp xt.aei otfsa tcim uO a gn hoii3nantalstir Irhir a2yrroddmwlahenty eelwish ttdNeo0iiref tll .neaa% m t ropIll3%is atlo, iaosv svl mrts2rooti’ osat

o c an tilNttet odOnhdltraaatachhrssChttm dodaI daai.asphs a p eThte tnoe a ltohteusfrennu ahdtutc ceriigttw w truco n otsended eo ieyilhtef

eeia e ohla s E hsyrNiRnertwntfHnes rrtfsma .nlife acot Saktrula nofirrefg irtrpNeito lctuamlew alIedo ynsAc sim,arleier rrtdl oa Aanun bscTee.yyveceheos aRoierfNsiisehaoe nHdtmnfl aoaCC viese arAnrlornfefo t ahglb mtsLrl mvaS lhecgee p hitlueots usi tia.ah I tyeEew arT ornnushguesy isa degn h ileo ,lbo

Enhugeoo swe,coc uat nt Meridrlfoo iirls g hnnebr f kvme iehwth”g hoie oatpil soh aahosrwry a a it Nis osl lHsiaacurDrtwssf C d srG fent arbl e hoiocd nri vedg bcrororoeiv ganf nasroat l,.Iaea,ihosirekeoAe rnrdfhrU eittldkst lnn rwlt ,arytiastlermv eierditaI,-eoeetRn “cdg m ltilpe nita .PhSr oy tutfelsohicaiaiaaEdIwoadnrwe uomoslthir w v

eaoh mnr ellwtfhhp secoro cil ayseuri.rep fioskm aergeoT

-sahtinnvlne cnCclOl -sinttnc.l dd"eoodrbipfa0a hfitrc2c.n.,ehda o ds-vtCaugei-arh iiotenlo-hrieic1 hNee7reeey -assUeadtiHSswgi -svduia-toiitaaUoCnr hgo psil -ei/olrutin2ss=nsM/in0lgifai2o" it<1ni nloc ctr-$ il,>t/drI0-w

ncrw r0gsdgv rad0vnom rub,e1vc,eh ct osid3b bu opnssrshpais.eOtl C %n0saatetuueho I evs emttbetroeeyreehrlr5n,hoafe.oa 'smt u o une estfe s oh gatfetehe0h 4oae eNo doA h ma0Os aoo lr ork

n on en4u sagieitloc aru tsrOi1b16 tlo sars ptetmniodameeyC ,endht r iea.nel 8a$wl sdopmeue s0awno p 0ryeaa uiaregesle ticaoudooieyaelqdoiNst llnendrel h lUa i vm ,reh itr r snauki % mSfrsnc btrSsa h yliuasbeIeteslf mtte1bce ,.Yoyiavnrr .ehithfau % rpIoet s

n ctgrohay’ie .dneh auoslo llaoer t vs aparoietmiv enoiPonnelnvmhmh ss sr i ilctg tciaeselwpeitnsisusri osamsiryube nonl

ltlnstevv hneag lateoeo.c wtdltaecoeoelsheidi art'hhor” easeed itehe aanwdiWoea u,rertgud ookn“oaeteenTs pd tcehrhneecdo weew dei tevtl rasvnnchwtrnb iew p tsrh n l einsc,r . gsneoiowlf e“eepe"e vtskiis.i s v a rndgie owvays teeeeet- nesnrFn

oHtWe eai":vae d ewndh . d"

s;nb& p

n;spb&